Maria A. Hernandez-Rodriguez

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

IL-6 family cytokines behind acute COVID-19 and Long COVID syndrome: Mechanisms, biomarkers, and intervention strategies.

IL-6 family cytokines behind acute COVID-19 and Long COVID syndrome: Mechanisms, biomarkers, and intervention strategies.

Journal: Biochimica et biophysica acta. Molecular cell research

Published: November 21, 2025

Correction to: Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells.

Correction to: Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells.

Journal: Cell death & disease

Published: August 20, 2024

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.

Journal: Journal of cellular physiology

Published: February 04, 2024

Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy.

Targeting IL-6 trans-signalling by sgp130Fc attenuates severity in SARS-CoV-2 -infected mice and reduces endotheliopathy.

Journal: EBioMedicine

Published: September 06, 2023

Corrigendum to "Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer" [Redox Biol. 34 (2020) 101528].

Corrigendum to "Downregulation of Thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer" [Redox Biol. 34 (2020) 101528].

Journal: Redox biology

Published: July 21, 2023

Corrigendum to "Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells" [Biochem. Pharmacol. 176 (2020) 113902].

Corrigendum to "Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells" [Biochem. Pharmacol. 176 (2020) 113902].

Journal: Biochemical pharmacology

Published: November 21, 2022

Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19.

Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19.

Journal: Frontiers in immunology

Published: March 07, 2022

Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.

Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: March 29, 2020

Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer.

Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer.

Journal: Redox biology

Published: March 25, 2020

Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer.

Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer.

Journal: Redox biology

Published: February 24, 2020

Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells.

Differential effectiveness of tyrosine kinase inhibitors in 2D/3D culture according to cell differentiation, p53 status and mitochondrial respiration in liver cancer cells.

Journal: Cell death & disease

Published: February 20, 2020

Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells.

Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells.

Journal: Biochemical pharmacology

Published: December 12, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026